Hancock Whitney Corp Lowers Position in The Cigna Group (NYSE:CI)
by Scott Moore · The Cerbat GemHancock Whitney Corp trimmed its position in shares of The Cigna Group (NYSE:CI – Free Report) by 18.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,541 shares of the health services provider’s stock after selling 827 shares during the period. Hancock Whitney Corp’s holdings in The Cigna Group were worth $978,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently made changes to their positions in CI. TCTC Holdings LLC acquired a new position in shares of The Cigna Group in the fourth quarter worth about $25,000. Collier Financial acquired a new stake in The Cigna Group in the fourth quarter valued at approximately $32,000. ORG Wealth Partners LLC purchased a new stake in shares of The Cigna Group in the fourth quarter valued at approximately $34,000. Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group during the 4th quarter worth approximately $37,000. Finally, Transce3nd LLC purchased a new position in shares of The Cigna Group during the 4th quarter valued at approximately $38,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.
The Cigna Group Stock Performance
NYSE:CI opened at $335.60 on Friday. The company’s 50-day moving average is $319.82 and its two-hundred day moving average is $310.69. The firm has a market capitalization of $91.85 billion, a price-to-earnings ratio of 27.42, a PEG ratio of 0.98 and a beta of 0.51. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83.
The Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the previous year, the business earned $6.79 earnings per share. Analysts forecast that The Cigna Group will post 29.77 EPS for the current year.
The Cigna Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be issued a $1.51 dividend. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a yield of 1.80%. The Cigna Group’s dividend payout ratio (DPR) is currently 49.35%.
Analysts Set New Price Targets
CI has been the subject of a number of research analyst reports. Royal Bank of Canada set a $355.00 price objective on shares of The Cigna Group in a research report on Friday, January 31st. Barclays lowered their price objective on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Sanford C. Bernstein cut The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 target price for the company. in a report on Thursday, February 6th. UBS Group lowered their price target on The Cigna Group from $410.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Finally, Cantor Fitzgerald increased their price objective on The Cigna Group from $350.00 to $365.00 and gave the company an “overweight” rating in a research note on Thursday, March 20th. Two research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $373.56.
Check Out Our Latest Report on The Cigna Group
Insider Buying and Selling at The Cigna Group
In other The Cigna Group news, insider Noelle K. Eder sold 9,944 shares of the company’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the transaction, the insider now directly owns 13,406 shares in the company, valued at $4,289,920. This represents a 42.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Elder Granger sold 2,376 shares of The Cigna Group stock in a transaction on Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the completion of the sale, the director now directly owns 5,471 shares of the company’s stock, valued at $1,697,924.85. The trade was a 30.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,751 shares of company stock valued at $13,603,991 over the last 90 days. 0.70% of the stock is owned by insiders.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Recommended Stories
- Five stocks we like better than The Cigna Group
- What Are Dividends? Buy the Best Dividend Stocks
- Short Sellers Gave Up on These 3 Names Recently
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 3 Boring Stocks Outperforming the Market This Year
- What Are Dividend Champions? How to Invest in the Champions
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).